Jingyi Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Replacement Therapy

Tyrosine Kinase

Optical Coherence Tomography

Top Venues

Thoracic cancer

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer (2024)
Kang Li, Bolin Chen, Jingyi Wang, Lin Wu
Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report. Thoracic cancer 15 (16) (2024)
Jingyi Wang, Lin Wu
An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer. Expert opinion on pharmacotherapy 23 (6) (2022)